Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
141.7 EUR | -4.90% | -6.31% | -10.06% |
Apr. 24 | IMCD's Spanish Unit to Buy Cobapharma | MT |
Mar. 27 | IMCD's Benelux Arm to Purchase Gova Ingredients | MT |
Sales 2024 * | 4.77B 5.1B | Sales 2025 * | 5.07B 5.42B | Capitalization | 8.07B 8.62B |
---|---|---|---|---|---|
Net income 2024 * | 296M 316M | Net income 2025 * | 332M 355M | EV / Sales 2024 * | 1.94 x |
Net Debt 2024 * | 1.17B 1.25B | Net Debt 2025 * | 978M 1.05B | EV / Sales 2025 * | 1.78 x |
P/E ratio 2024 * |
27.5
x | P/E ratio 2025 * |
24.8
x | Employees | - |
Yield 2024 * |
1.56% | Yield 2025 * |
1.68% | Free-Float | 98.13% |
Latest transcript on IMCD N.V.
1 day | -4.90% | ||
1 week | -6.31% | ||
Current month | -13.25% | ||
1 month | -13.20% | ||
3 months | +0.14% | ||
6 months | +28.24% | ||
Current year | -10.06% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 20-06-29 | |
Hans Kooijmans
DFI | Director of Finance/CFO | 63 | 11-02-28 |
Marcus Jordan
COO | Chief Operating Officer | 50 | 97-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 18-05-08 | |
Amy Motto
BRD | Director/Board Member | 52 | 20-06-29 |
Willem Eelman
BRD | Director/Board Member | 60 | 22-05-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.06% | 303 M€ | +12.60% | ||
0.37% | 18 M€ | +3.79% | - | |
0.21% | 2 M€ | +7.72% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 141.7 | -4.90% | 511,882 |
24-04-25 | 149 | -1.65% | 161,220 |
24-04-24 | 151.5 | -1.85% | 152,814 |
24-04-23 | 154.4 | +1.88% | 115,921 |
24-04-22 | 151.5 | +0.17% | 77,364 |
Real-time Euronext Amsterdam, April 26, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.06% | 9.09B | |
+25.96% | 1.02B | |
+8.23% | 174M | |
+36.99% | 142M | |
+4.24% | 116M | |
-4.88% | 102M | |
+7.15% | 88.49M |
- Stock Market
- Equities
- IMCD Stock